Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - VALEANT PHARMACEUTICALS INTERNATIONAL | a56989e8vkza.htm |
| EX-99.3 - EX-99.3 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56989exv99w3.htm |
| EX-99.2 - EX-99.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56989exv99w2.htm |
| EX-99.1 - EX-99.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a56989exv99w1.htm |
Exhibit 23.1
Consent of Independent Auditor
We consent
to the incorporation by reference in the Registration Statement No.
333-112904 on Form S-3 and Nos. 33-56971, 333-81383, 333-73098,
333-85572, 333-109877, 333-109879, 333-142651, 333-156931 and
333-160393 on Form S-8 of Valeant Pharmaceuticals of our report dated March 8, 2010, relating to our
audit of the consolidated financial statements of Princeton Pharma Holdings, LLC and Subsidiary as
of and for the year ended December 31, 2009, included in this Current Report on Form 8-K/A.
/s/ McGladrey & Pullen, LLP
Blue Bell, Pennsylvania
August 12, 2010
Blue Bell, Pennsylvania
August 12, 2010